The pressure to deliver novel therapeutics to people is constantly increasing, and biopharmaceutical companies are increasingly turning to specialized research and development offerings to accelerate the entire process. These solutions encompass a extensive range of capabilities, from early-stage target validation and lead optimization to pre-clini